Daily research

Tuesday, November 10, 2026

Every trading morning Matador ranks the names most likely to move: the catalyst, the options flow behind it, and the risks that could break it.

Market context

13 tickers · published 7:41 AM EST

S&P 500 futures are mixed at 7,578 (+0.06%), Nasdaq 100 futures -0.24%, Dow futures +0.29% as of ~5:30 AM ET. Monday was the S&P's best single session since April (+2.35% to 7,549.94), with Dow +2.15%, Nasdaq +2.74%, Russell 2000 +3.15% — the SOX semiconductor index surged ~7% (best day since July) while NVDA fell 4.3% in divergence. Global markets extended gains Tuesday: Nikkei +2.9% (reclaiming 60,000), KOSPI +4.4%, Taiwan +3%, European Stoxx 600 +1.3%. VIX fell 22% Monday to 19.92 (term structure back in contango); one-day vol prices ~0.79% for CPI day — a benign but binary setup. 10-Year Treasury at 4.868%, 2-Year at 4.549%.

Support7,400
Resistance7,650
VIX19.92
Sector rotation

INFLOWS (Monday's session, confirmed by price action): Industrials (XLI +3.8%, best sector), Technology/Semiconductors (XLK +3.68%, SOX +7%, ex-NVDA), Consumer Discretionary, and Financials. OUTFLOWS / LAGGING: Energy (XLE <1% gain despite broad rally as oil prices plunge on Iran diplomacy), Consumer Staples (XLP <1%), Gold/Miners (fading Tuesday premarket -0.4% to -1.8% on rising hike odds). STRUCTURAL: Sector rotation in 2026 has been from mega-cap tech toward Industrials (+16% YTD), Consumer Defensives (+13.3% YTD), and Energy (until last week's oil shock). The bounce Monday suggests tech/semis may reassert short-term leadership if CPI cooperates, but governance concerns at NVDA and financing stress at AI clouds create intra-sector divergence.

Tonight's earnings risk

CRWV

Geopolitical headlines

  • •US-Iran Diplomacy / Oil Shock: President Trump told CNN that resuming strikes on Iran is 'highly unlikely' if negotiations progress, sending Brent crude below $90 for the first time since August and Brent down ~16% last week — its steepest weekly drop since COVID. A third US carrier remains in theater and attacks near the Strait of Hormuz continue, keeping a residual risk premium in energy and shipping stocks.
  • •Nvidia CEO / China Espionage Probe: Nvidia's board launched an independent investigation into CEO Jensen Huang after reports linked him to Alice Huang, an alleged Chinese intelligence asset. The FBI is investigating; a shareholder class action has been filed; and Huang's affairs are alleged to have facilitated ~$7.5B in chip shipments through sanctioned Chinese firms. The stock is 23% below its Oct 28 peak and faces a potential 4–6 week board-investigation overhang into the Dec 9 FOMC.
  • •China Tariff Truce Extended: Beijing extended its suspension of the additional 24% tariff on US imports by two months from November 10, while maintaining the base 10% levy. APEC leaders — including Trump and Xi — are expected to meet in Shenzhen November 18–19, making trade and AI-chip export policy a live headline risk into the end of month.

Upcoming events

  • •🔴 TODAY 8:30 AM ET — October CPI (last reading before Dec 9 FOMC): consensus +0.3% m/m headline, +0.2% m/m core. BLS will not publish 12-month change because Oct 2025 data was not collected during the government shutdown. Fed Gov. Waller has signaled a 25bp December hike as his base case but said 50bp 'should be considered' if core prints at or above 0.3%.
  • •🔴 TODAY AMC 5:00 PM ET — CoreWeave (CRWV) Q3 2026 Earnings: consensus EPS -$1.17 to -$1.53 on ~$3.54B revenue (+159% YoY). Options pricing a ~21% move in either direction.
  • •TODAY — Anthropic (ANT) IPO Roadshow Begins: Updated S-1 filed 11/10 with $70–$78/share price range, 825M shares, targeting up to $90.4B total raise including private placement. Earliest trading debut is Nov 16; targeting week of Nov 18. Watch for read-through on GOOGL, AMD, NVDA, MU, AVGO as cornerstone investors.
  • •TODAY 10:50 AM ET — Dallas Fed President Logan speaks.
  • •TODAY 1:30 PM ET — Kansas City Fed President Schmid speaks.
  • •TODAY 3:30 PM ET — Fed Vice Chair Bowman speaks at Council on Foreign Relations.
  • •WEDNESDAY (expected) — 10-Year Treasury Auction: watch for yield reaction post-CPI.
  • •THURSDAY Nov 12 — Applied Materials (AMAT) earnings AMC: key AI capex read-through.
  • •MONDAY Nov 17 (expected, unconfirmed) — Nvidia (NVDA) Q3 Earnings: critical test of AI chip demand vs. governance discount.
  • •NOV 18–19 — APEC Summit, Shenzhen: Trump-Xi bilateral expected; tariff and AI-chip export policy in focus.

Hot themes

  • •AI CapEx & Governance Risk: The AI infrastructure trade is at an inflection point. CoreWeave earnings tonight are the first live test of whether leveraged AI clouds can survive rising financing costs (interest expense guided at $860M–$940M vs. ~$3.5B revenue). The Nvidia CEO scandal injects governance and China-export risk into the sector's most important stock. Anthropic's $1.4T-valuation IPO roadshow beginning today will set a template for private AI valuations and directly impacts GOOGL, AMD, NVDA, MU, and AVGO as named cornerstone investors.
  • •October CPI vs. Fed Hike Path: Today's 8:30 AM CPI is the single most market-moving print of the week. Fed Gov. Waller has explicitly put a 50bp December hike on the table if core prints ≥0.3%. Markets price an 82.2% probability of a December hike already, but a hot print risks re-pricing the terminal rate and hammering rate-sensitive growth, real estate, and long-duration tech. Oil's sharp decline softens the energy component and may offer a slight disinflationary tailwind.
  • •GLP-1 FDA Safety Warning — Novo & Lilly: The FDA on Nov 9 required all GLP-1 drug makers (Novo Nordisk, Eli Lilly, Sanofi, et al.) to add a NAION (non-arteritic anterior ischemic optic neuropathy / 'eye stroke') warning to their labeling after finding a 1.7x increased risk in meta-analysis of 126 trials. No causal mechanism was established and Europe's EMA had already flagged semaglutide in 2025, so the marginal news is modest — but headline-driven put buying is likely in NVO and LLY.

Risk flags

October CPI Binary — 50bp Hike Risk

Fed Gov. Waller said a 0.3% core print puts a 50bp December hike 'on the table.' A hot print (≥0.3% core) could whipsaw the rally, hit growth/tech, and invert the yield curve further. A cool miss (<0.2%) would validate the recovery and push Nasdaq higher.

CRWV Earnings Execution Risk

CoreWeave reports AMC tonight. The stock has fallen after 5 of its 6 earnings reports. Options price a 21% move (wider than the 16.4% historical average), meaning IV is rich and premium selling is mechanically attractive — but management's Q4 and 2026 guidance on debt, Texas permitting, and backlog conversion will determine direction. Avoid naked directional bets; prefer defined-risk structures.

Nvidia CEO / China-Chips Governance Overhang

Board investigation could take 4–6 weeks per Dan Ives. Any escalation (congressional inquiry, DOJ subpoena, Huang departure) could send NVDA below the $160 technical level and reprice the entire AI trade. Watch for board statements and any Trump DOJ comments.

Anthropic IPO Market Impact

Roadshow begins today; pricing expected mid-November. At $1.4T fully diluted valuation this would be the largest-ever US IPO. Index-fund forced buying upon Nasdaq inclusion could lift AI ecosystem stocks, but a poor book or pricing cut would validate last week's AI valuation concerns and pressure GOOGL, AMD, and infrastructure names.

Strait of Hormuz — Oil Tail Risk

Trump's diplomatic language has pushed Brent below $90, but ongoing tanker attacks near the Strait of Hormuz keep a ~$5–10 risk premium embedded. Any resumption of US-Israeli strikes would spike oil >$100, re-import inflation, and derail the market recovery.

GLP-1 Label Warning Litigation Tail

FDA NAION warning on all GLP-1s is a headline risk for NVO and LLY. No causal link established; Europe already acknowledged the risk in 2025. Incremental litigation costs could mount but are unlikely to materially impair earnings unless a causal mechanism is proven.

Neutron / CRWV Texas Data Center Permitting

Texas's new Democratic Governor Gina Hinojosa has called for a statewide pause on AI data center construction. This directly threatens CoreWeave's Texas capex plans. Any negative commentary on this topic in tonight's earnings call could be a secondary leg down for CRWV and AI infrastructure peers.

#01

CRWV

CoreWeave Inc.

9.2Alpha
Earnings — AMC TonightNeutral

CoreWeave reports Q3 2026 after the close at 5 PM ET with consensus expecting ~$3.54B revenue (+159% YoY) and a ~$1.17–$1.53 EPS loss. The stock is 65–70% below its 2026 high as the market has repriced the leveraged AI-cloud model. Options price a 21.1% move — the widest ever pre-print implied move for the company and far above the 16.4% historical post-earnings average. The edge lies in the vol-sell: IV is richer than the catalyst warrants on a risk-adjusted basis. Direction hinges entirely on interest expense guidance, Texas permitting commentary, and backlog conversion pace.

  • ›Consensus revenue ~$3.54B, +159% YoY; Q3 interest expense guided $860M–$940M (nearly 25% of revenue), and capex guidance of $11.5B–$13.5B for the quarter — the financing math is the debate, not demand.
  • ›Options traders pricing a 21.1% move either direction; the stock has fallen after 5 of its 6 earnings reports with PEAD of -59.8% since the last report on Aug 11.
  • ›Backlog of ~$104–125B+ provides multi-year revenue visibility, anchored by Microsoft contracts; CoreWeave's 2032 bonds traded as low as 74.75 cents on Nov 5 with spreads near 1,200bps — credit stress pre-dates the midterm election politics.
  • ›Wall Street average price target ~$128 (Moderate Buy, 21 Buys / 5 Holds / 3 Sells), implying ~160% upside; ARK Invest sold 412,666 shares at ~$18M on Thursday, while Morningstar retained $108 fair value with 'Very High Uncertainty'.

Flow Put/call ratio 0.96x on Nov 13 expiry (slight bullish skew); upper price bound on those contracts implies 18% rally ceiling from current levels. Large open interest in $55C and $40P for Nov 14 expiry; IV crush post-print expected.

⚠ Texas Governor Gina Hinojosa's call for a statewide pause on AI data center construction is an underappreciated specific risk to CoreWeave's capex plan; any mention tonight pressures stock further regardless of revenue beat.

Trade idea for CRWV is for Matador members
Impl Move ±21.1%
IV Rank 88
Rel Vol 2.8×
Short 14.2%
Liquidity good
Earnings 11/10 AMC
#02

AMD

Advanced Micro Devices Inc.

8.7Alpha
Analyst Upgrade + Earnings MomentumBullish

AMD surged 13.3% Monday (best session in 6 months) as investors rotated from NVDA governance risk into the clearest AI-chip alternative, then received a fresh Oppenheimer upgrade to Outperform with a $600 price target Tuesday premarket (+4.2% further to ~$467). The fundamental backdrop is robust: Q3 data center revenue surged 97% YoY to $8.5B, full-year 2027 guidance implies >80% revenue growth, and the Anthropic partnership (a cornerstone Anthropic IPO investor) ramps in Q1 2027. At ~$449–467, AMD sits 26% below its 1-month high despite being structurally the main NVDA alternative.

  • ›Oppenheimer upgraded to Outperform, $600 PT (34% upside from prior close); Freedom Broker raised PT to $620 from $460; of 56 analysts covering AMD, 48 have Buy or Strong Buy ratings.
  • ›Q3 2026 record revenue $13.38B, +45% YoY, beat estimates by 2.2%; Q4 guidance ~$17B (+/- 3%) well above $16.23B consensus; data center revenue up 97% to $8.5B (64% of total sales).
  • ›Anthropic, Meta, Microsoft, OpenAI, Oracle among early AMD Helios GPU customers; Oppenheimer models 135% data center revenue growth in 2027 as MI500 GPU line launches in H2 2027.
  • ›AMD EPYC processors are now powering Google Cloud's TPU 8tx host servers, expanding AMD's role in the AI infrastructure stack beyond compute accelerators.

Flow Call sweeps reported on Nov 6 on the SOXX bounce; Cboe data showed mixed but net-bullish options sentiment. Options volume elevated post-upgrade; likely call buying in Dec $480–$520 range on the Anthropic IPO catalyst read-through.

⚠ AMD still trades at ~95x earnings and remains below its 20-day ($527) and 50-day ($547) moving averages — MACD is below signal line, suggesting near-term technical resistance; gap up from $449 to $467+ could partially fill.

Trade idea for AMD is for Matador members
Impl Move ±6.5%
IV Rank 62
Rel Vol 1.7×
Short 3.8%
Liquidity tight
#03

NVDA

NVIDIA Corporation

8.3Alpha
CEO Governance Crisis + Pre-Earnings (Nov 17 expected)Neutral

NVDA closed -4.3% Monday to $178.67 (23% below its Oct 28 high of $220) amid a board investigation into CEO Jensen Huang's affair with Alice Huang, an alleged Chinese intelligence asset. Reports allege the relationship facilitated ~$7.5B in chip shipments through Megaspeed. The FBI is investigating. A shareholder class action has been filed. A 4–6 week board investigation creates a persistent governance discount on what is otherwise the world's most critical AI-chip supplier. Earnings are expected Nov 17; that report can clear the demand narrative but cannot resolve the governance gap.

  • ›Board launched independent investigation after Huang admitted an affair in a staff email; Wedbush/Yorkville Ives estimates 85% probability Huang remains CEO after the probe, with 15% removal risk — 'a black eye moment' that will create congressional inquiries.
  • ›Short seller Culper Research estimates >20% of Nvidia's FY26 compute revenue remains China-driven, and Megaspeed is alleged to have purchased >$4.8B of NVDA chips over two years; DOJ/export-control risk is real and underpriced.
  • ›NVDA stock up ~2% premarket to ~$182 as Trump said 'I think he'll be in good shape' — this is a presidential comment, NOT a board update; treat with caution as a temporary overhang stabilizer.
  • ›Earnings expected Nov 17 (unconfirmed); Wedbush maintains Outperform with $345 PT and argues NVDA could grow >70% next year trading at ~10x 2028 earnings — the demand thesis is intact, the governance discount is the man, not the chip.

Flow NVDA put skew elevated; implied vol elevated across the Nov/Dec term structure as the market prices two catalysts (board update + earnings). Heavy open interest in Nov 21 $170P and $200C. Net put buying on Monday's selloff.

⚠ Any escalation — DOJ subpoena, congressional hearing date set, or second Culper-style research report on Megaspeed chip flows — could send stock through the $160 technical level and reprice the AI trade broadly.

Trade idea for NVDA is for Matador members
Impl Move ±9.5%
IV Rank 79
Rel Vol 2.4×
Short 1.2%
Liquidity tight
Earnings 11/17 AMC
#04

NVO

Novo Nordisk A/S

7.8Alpha
FDA Safety Warning — GLP-1 / NAIONBearish

The FDA on November 9 required Novo Nordisk and all GLP-1 drug makers to add a NAION ('eye stroke') warning to their labeling after a meta-analysis of 126 trials found 6.4 NAION cases per 100,000 person-years vs. 3.8 for placebo — a ~1.7x elevated risk. No causal mechanism was identified and Europe's EMA had already flagged this for semaglutide (the active ingredient in Ozempic/Wegovy) in 2025, so the marginal surprise is limited. However, headline-driven put activity and litigation fears create short-term headwinds for NVO in a market already sensitive to GLP-1 negative catalysts.

  • ›FDA requires NAION warning on ALL currently marketed GLP-1 products including Novo's Ozempic, Wegovy, and Rybelsus — the warning goes in the 'Warnings and Precautions' section (not a black box warning, which already exists for thyroid tumor risk).
  • ›Novo Nordisk stated 'the data do not establish a cause-and-effect relationship' and says it 'remains confident in the benefit-risk profile.' The EMA already listed NAION as a 'very rare' side effect in 2025, limiting incremental surprise.
  • ›NAION risk appears extremely rare: 10 probable events identified in 134,000 patients across 126 trials; real-world observational studies have been mixed, limiting a liability overhang.
  • ›Rising GLP-1 lawsuit filings (stomach paralysis and now NAION) add to Novo's litigation reserve requirements, but the core obesity + diabetes growth narrative remains intact; any selloff <5% could be a medium-term buy-the-dip.

Flow Elevated put buying in NVO Nov and Dec strikes following FDA announcement Monday; put/call skew has shifted bearishly. Watch $95P and $90P open interest for Nov 21 expiry.

⚠ If a future randomized trial establishes causality (not currently established), NVO's label could escalate to a black-box warning, materially impairing prescribing rates. Monitor any new study publications.

Trade idea for NVO is for Matador members
Impl Move ±4.0%
IV Rank 55
Rel Vol 2.1×
Short 2.3%
Liquidity good
#05

SANM

Sanmina Corporation

7.6Alpha
Earnings Beat + Guidance RaiseBullish

Sanmina surged ~19–20% premarket to ~$179 after reporting Q4 revenue of $3.86B — a massive 10.8% beat vs. $3.48B consensus and +84% YoY from $2.10B. FY2027 EPS guidance of $15.50–$17.50 blew past the FactSet consensus. As an electronic manufacturing services (EMS) provider, Sanmina is a direct pick-and-shovel beneficiary of AI hardware production ramp, server builds, and industrial reshoring. Post-earnings gap-ups in EMS names have shown persistent momentum as the market reprices AI supply-chain stocks.

  • ›Q4 revenue $3.86B vs. $3.48B estimate, a 10.8% upside beat; +84% YoY growth from $2.10B prior year — indicating a step-change in AI-related manufacturing orders.
  • ›FY2027 EPS guidance $15.50–$17.50 meaningfully above Street consensus; market cap ~$8B implies the guidance still puts P/E at reasonable levels for an AI supply chain compounder.
  • ›AI server and data center component demand, reshoring of electronics manufacturing, and defense electronics are structural tailwinds that make this more than a one-quarter story.
  • ›Stock was essentially flat YTD before this print; the gap creates a fresh breakout to multi-year highs.

Flow Limited options liquidity in SANM (small-mid cap); look for elevated call volume at the $180 and $200 strikes for Dec expiry if options market makers have adjusted for the gap.

⚠ EMS companies are capital-light assemblers with thin margins; any customer concentration (e.g., major hyperscaler pull-back on capex) could immediately hit revenue. The 19% gap is large — wait for a partial intraday pullback before initiating longs.

Trade idea for SANM is for Matador members
Impl Move ±8.0%
IV Rank 71
Rel Vol 8.4×
Short 6.1%
Liquidity moderate
#06

RKLB

Rocket Lab USA Inc.

7.5Alpha
Earnings Beat — Post-Print Dip OpportunityBullish

Rocket Lab posted Q3 2026 results AMC Monday: revenue $267.8M (+73% YoY), beating the $258M estimate by 3.8%; backlog surged 52% sequentially to a record $3.57B; first-ever positive GAAP operating cash flow of $7.2M. Q4 guidance: $270M–$290M revenue (midpoint $280M vs. $266M estimate). Despite the blowout numbers, the stock sold off ~6% from $58.67 to ~$54.97 on profitability concerns (adj. EBITDA loss widened to -$18M on Neutron R&D) and the news that Neutron's first launch slips to 2027. The selloff appears overdone given the backlog quality: $515M+ in Neutron launch contracts signed, base price raised to $70M per mission.

  • ›Record Q3 revenue $267.8M, +73% YoY, +14.4% sequentially — exceeded guidance of $250M–$265M; backlog $3.57B (+52% sequentially from $2.4B), including 117 launch slots and 55+ spacecraft.
  • ›Secured >$515M in Neutron launch contracts from constellation operators; Neutron base price raised to $70M per mission for several new bookings, with CFO Spice signaling prices will 'logically rise from that new baseline.'
  • ›Q4 guidance: revenue $270M–$290M, adj. gross margin 39%–41% (sequential improvement), adj. EBITDA -$14M to -$20M. Full-year 2026 revenue approaching $1B, 69 percentage points of gross margin improvement since 2020.
  • ›Pending Iridium Communications acquisition adds recurring cash-generative service revenue; Space Systems backlog of $1.7B (48% of total) now rivals Launch for the first time, reflecting the company's end-to-end strategy.

Flow Post-earnings options activity expected to show put closing (covering short from last night) and fresh call buying on the dip. Watch Nov 21 $58C and Dec 19 $65C for institutional follow-through.

⚠ Neutron's first launch has now slipped to 2027 for the third time — each prior delay was replaced before it closed. The forward loss reserve on Neutron Flight II and the negative free cash flow profile will persist until Neutron is in production. Buy on sentiment dip, not on a Neutron timeline.

Trade idea for RKLB is for Matador members
Impl Move ±7.0%
IV Rank 58
Rel Vol 2.2×
Short 8.3%
Liquidity moderate
#07

TSM

Taiwan Semiconductor Mfg. Co.

7.1Alpha
October Revenue Beat + AI Chip DemandBullish

TSMC reported October 2026 monthly sales of $17.88B, up 59.7% YoY and +14.7% MoM — the strongest year-over-year growth rate since the AI CapEx buildout began. TSMC is the foundry backbone of the entire AI semiconductor ecosystem, manufacturing chips for NVDA, AMD, Apple, and Broadcom. Despite the macro uncertainty and NVDA governance overhang, TSMC's data confirms sustained silicon demand is real and accelerating. Stock is marginally positive premarket with low vol.

  • ›October 2026 revenue TWD 580.1B (~$17.88B), +59.7% YoY and +14.7% MoM — accelerating into the year-end quarter as hyperscaler customers pull forward orders ahead of Blackwell/MI300X production ramps.
  • ›TSMC's N3/N2 advanced node capacity is fully sold out through 2027 per multiple supply-chain checks; pricing power is at a cycle high with ASP increases for CoWoS advanced packaging.
  • ›Taiwan TWSE gained ~3% Tuesday, lifting TSM ADR further; KOSPI +4.4% (Samsung/SK Hynix HBM3E read-through positive for the entire memory/foundry ecosystem.
  • ›The revenue print is the clearest data point refuting the thesis that AI CapEx is about to roll over — a direct counterweight to CRWV's financing fears and NVDA's governance noise.

Flow Steady institutional call buying in TSM Dec $230/$250 range; IV relatively low for a name of this size (~35 IV rank), making long calls reasonably priced. No unusual sweep activity noted Tuesday.

⚠ Taiwan local elections November 28 and ongoing PLA air-space incursions create geopolitical tail risk. ADR illiquidity vs. TWD-listed shares can widen spreads in premarket. Avoid TSM as a reaction trade to tonight's CRWV print.

Trade idea for TSM is for Matador members
Impl Move ±3.5%
IV Rank 35
Rel Vol 1.3×
Short 0.9%
Liquidity good
#08

LLY

Eli Lilly and Company

7.0Alpha
FDA Safety Warning — GLP-1 / NAIONBearish

Eli Lilly joins Novo Nordisk in facing FDA-mandated NAION warning labels on its GLP-1 portfolio (Mounjaro, Zepbound, Foundayo). Lilly said it is 'carefully evaluating the update.' While the fundamental narrative (GLP-1 market leader, Zepbound outpacing Wegovy in US share gains) is unchanged, headline risk and litigation-driven put buying create a short-term bearish overhang. Lilly has greater GLP-1 market concentration risk than Novo, as GLP-1 drugs represent a higher percentage of its near-term revenue growth.

  • ›FDA requires NAION risk disclosure in Warnings and Precautions section for all Eli Lilly GLP-1 products (Mounjaro/tirzepatide and Zepbound/tirzepatide) — not a black-box warning.
  • ›Lilly spokesperson stated the company is 'carefully evaluating' and will 'respond to FDA promptly.' The European EMA already classified semaglutide NAION risk as 'very rare' in 2025, partially de-risking the incremental surprise.
  • ›Unlike Novo, Lilly's tirzepatide (a dual GIP/GLP-1 agonist) has a slightly different mechanism; the FDA warning applies across all GLP-1 RA mechanisms, so Lilly gets no differentiation credit.
  • ›Litigation wave risk: Ozempic/stomach-paralysis lawsuits already in progress; NAION adds a new legal theory and could attract plaintiff law firms to file in next 30–60 days.

Flow Put skew elevated post-FDA announcement Monday; heavy Nov 21 $700P buying noted. IV rank elevated vs. trailing 1-year at ~58.

⚠ Lilly is a structurally superior business vs. Novo with a broader pipeline (Alzheimer's, oncology), so this is a tactical short or hedge, not a fundamental short. Cover if LLY holds above its 50-day moving average on the initial reaction.

Trade idea for LLY is for Matador members
Impl Move ±4.5%
IV Rank 58
Rel Vol 1.6×
Short 1.7%
Liquidity good
#09

RIOT

Riot Platforms Inc.

6.8Alpha
Analyst Upgrade — Jefferies BuyBullish

Jefferies upgraded Riot Platforms to Buy from Hold, citing the Corsicana, Texas data-center land lease as a highly undervalued asset — estimating it alone is worth ~$16/share. Jefferies models capex of ~$6M per megawatt of IT capacity (vs. $11M–$15M for a typical build) and estimates the land lease could generate an average yield of ~33%. As a Bitcoin miner with a world-class power footprint, Riot sits at the intersection of two hot themes: AI data-center infrastructure and crypto's directional recovery. Up ~2% premarket on the upgrade.

  • ›Jefferies estimates Corsicana land lease alone is worth ~$16/share — at current prices this represents >40% of Riot's market cap, suggesting the broader business is being given minimal credit.
  • ›Riot's low capex model ($6M/MW vs. $11–15M industry average) creates structural cost advantage for data-center monetization; the lease optionality is similar to how cell tower companies re-rated when data demand rose.
  • ›Bitcoin at $74K (down 1.6% over 24h) represents headwind if BTC continues to slide on hike odds; however, miners typically squeeze on BTC volatility spikes, and Riot's hash-rate leadership provides cushion.
  • ›Post-midterm Democratic sweep raised concerns about stricter crypto and AI data-center regulation — but Riot's operational leverage to Texas land means regulatory risk is limited vs. software-layer crypto firms.

Flow Call sweeps noted in RIOT on Nov 7 (pre-upgrade leak?) in Dec $45C and $50C. Put/call skew slightly bullish. IV rank elevated from last week's selloff but not at extremes.

⚠ Texas Governor Hinojosa's call for a data-center construction pause is a direct risk to the Corsicana thesis — monitor for any executive orders or state legislation. BTC downside below $70K would materially impair mining economics.

Trade idea for RIOT is for Matador members
Impl Move ±8.0%
IV Rank 64
Rel Vol 1.9×
Short 11.4%
Liquidity moderate
#10

TTWO

Take-Two Interactive Software Inc.

6.6Alpha
Earnings Beat + GTA 6 ConfirmationBullish

Take-Two reported fiscal Q2 earnings with an adj. EPS beat ($1.00 vs. $0.94 estimate) and revenue beat ($1.60B vs. $1.58B). The company confirmed GTA 6 remains on track, and management projected the launch quarter will generate more than double the revenue of the prior year period — a potential $4B+ quarter. Up ~4% premarket. IV crush is complete post-earnings, making this a momentum continuation trade rather than an event play.

  • ›Adj. EPS $1.00 vs. $0.94 consensus; revenue $1.60B vs. $1.58B estimate — solid beat on both lines with no major guidance cut.
  • ›GTA 6 on track with management projecting the launch quarter to deliver sales more than double year-ago levels; this is the most anticipated game launch in history with presale tailwinds well into 2027.
  • ›Take-Two's mobile gaming segment (Zynga integration) continues to stabilize, reducing the binary GTA-dependency that has historically pressured the stock.
  • ›Stock up ~4% premarket; IV crush complete, so directional momentum plays (not straddles) are the appropriate structure post-earnings.

Flow Post-earnings, expect call spreads to be initiated for Dec/Jan expiry targeting the GTA 6 launch momentum. No unusual flow pre-print noted. IV has crushed; long options are now cheaper.

⚠ GTA 6 has been delayed multiple times before — any further slip in release date would be a catastrophic catalyst reversal. Avoid holding into any GTA news cycle with large directional risk.

Trade idea for TTWO is for Matador members
Impl Move ±5.0%
IV Rank 42
Rel Vol 2.3×
Short 5.2%
Liquidity good
#11

BW

Babcock & Wilcox Enterprises Inc.

6.4Alpha
Earnings Beat — Nuclear/Industrial MomentumBullish

Babcock & Wilcox reported Q3 revenue of $290.8M and EPS of $0.02, sending shares up ~15% premarket. As a nuclear and industrial services company, BW benefits from the AI power demand surge — data centers require reliable baseload power, and nuclear is the fastest-growing energy alternative narrative post-oil-shock. The 15% gap on modest earnings suggests the market is reassessing BW's strategic positioning in the nuclear renaissance trade.

  • ›BW reported Q3 revenue of $290.8M (details on beat magnitude not fully disclosed premarket); EPS of $0.02 reflects early-stage profitability on a turnaround story.
  • ›Nuclear power demand is surging as AI data centers require 24/7 baseload electricity; BW provides steam generation, boiler services, and nuclear-grade equipment.
  • ›The post-election Democratic sweep initially raised fears of AI data-center slowdown, but nuclear power remains bipartisan; BW is insulated from AI regulation risk relative to pure-play AI stocks.
  • ›Thin options liquidity in BW makes this primarily a stock/sector momentum trade rather than an options structure; use tight stops given the gap-up nature.

Flow Very limited options liquidity in BW; bid/ask spreads are likely >$1.00. Avoid options structures; trade the stock with a defined stop below the gap ($11.50 area).

⚠ BW has weak price trend ratings (long, medium, short term bearish per Benzinga Edge) and the company is at an early stage of nuclear project ramp — revenue can be lumpy and guided revenue may disappoint if project timelines slip.

Trade idea for BW is for Matador members
Impl Move ±6.0%
IV Rank 70
Rel Vol 6.1×
Short 9.7%
Liquidity poor
#12

MU

Micron Technology Inc.

6.2Alpha
Sector Rebound + HBM Demand Read-throughBullish

Micron surged 6.3% Monday on the semiconductor sector rebound (SOX +7%). As the leading US producer of HBM3E memory chips (High Bandwidth Memory) for NVIDIA's Blackwell GPUs and AMD's MI300X, Micron is a direct beneficiary of AI CapEx acceleration. The TSMC October sales data (+59.7% YoY) confirms the silicon demand is real. IV has normalized slightly after last week's selloff (MU was -12%+ in the SOX rout), creating moderately attractive entry for call spreads.

  • ›MU surged 6.3% Monday as the SOX reclaimed the 10,000 level; premarket is flat to slightly positive — a sign of consolidation after a one-day mean-reversion bounce.
  • ›HBM3E (High Bandwidth Memory) demand from AI GPU customers is fully sold out through mid-2027 per Micron's last earnings call; MU estimates HBM addresses a $100B+ market by 2030.
  • ›TSMC's October +59.7% YoY revenue confirms sustained foundry demand, which directly supports Micron's DRAM and NAND orders from the same hyperscaler customers.
  • ›MU is currently trading well below its 52-week high; Wall Street consensus is Strong Buy with significant upside potential as the AI memory cycle re-accelerates.

Flow MU call sweeps were noted on Nov 6 (the Friday of the SOX selloff bounce); Monday's vol activity showed large call blocks in Dec $120 and $130 strikes. Net bullish positioning.

⚠ If tonight's CPI is hot and the market sells off on 50bp hike fears, MU will underperform as a high-beta cyclical semiconductor. Time entry after the 8:30 AM CPI print, not before.

Trade idea for MU is for Matador members
Impl Move ±5.0%
IV Rank 52
Rel Vol 1.5×
Short 2.6%
Liquidity tight
#13

GOOGL

Alphabet Inc.

6.0Alpha
Anthropic IPO Halo — Cornerstone InvestorBullish

Alphabet is a confirmed cornerstone investor in the Anthropic IPO (>5% stake, Class A shares without votes), meaning GOOGL will likely receive an Anthropic equity re-rating as the IPO roadshow — beginning today — crystallizes Anthropic's $1.4T fully diluted valuation. GOOGL's Google Cloud grew 103% YoY to $30.7B in Q3. The stock closed +1.18% Monday; AMD's EPYC processors now power Google Cloud's TPU 8tx host servers, further validating Google Cloud's AI infrastructure leadership.

  • ›Alphabet holds >5% of Anthropic post-IPO at a valuation of ~$1.4T fully diluted; at the $70–$78/share price range, GOOGL's stake in ANT alone could be worth tens of billions in mark-to-market value.
  • ›Google Cloud Q3 2026 revenue grew 103% YoY to $30.7B — the fastest growth among the major cloud providers (Azure: +48%, AWS: +39%), driven by AI workloads on TPU 8tx and Gemini-powered services.
  • ›AMD EPYC processors confirmed to power Google Cloud TPU 8tx host servers — a partnership that reduces Google Cloud's Intel CPU dependency and broadens its AI infrastructure stack.
  • ›If Anthropic's IPO prices well (at or above the $78 high end), it validates AI valuations broadly and directly benefits GOOGL stock as the most direct structural beneficiary.

Flow Steady institutional call activity in GOOGL Dec $300 and $320 strikes; IV is relatively muted given the company's size. Anthropic IPO catalyst could drive a re-rating of the AI ecosystem multiple broadly.

⚠ If the Anthropic roadshow encounters weak demand or a price range cut (possible given last week's AI selloff), GOOGL would see a secondary negative read-through. Additionally, DOJ antitrust remedies in the Google Search case may require GOOGL to divest assets or restrict business lines.

Trade idea for GOOGL is for Matador members
Impl Move ±3.0%
IV Rank 29
Rel Vol 1.2×
Short 0.7%
Liquidity tight

Get the trade on every name

Members see the options structure for each pick, backtest it in one click, and read the full archive.

Disclaimer: This research is compiled from publicly available information for educational and analytical purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Always conduct your own due diligence.